266 related articles for article (PubMed ID: 10221757)
1. Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.
Cheer JF; Cadogan AK; Marsden CA; Fone KC; Kendall DA
Neuropharmacology; 1999 Apr; 38(4):533-41. PubMed ID: 10221757
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.
Fone KC; Robinson AJ; Marsden CA
Br J Pharmacol; 1991 Jun; 103(2):1547-55. PubMed ID: 1832068
[TBL] [Abstract][Full Text] [Related]
3. (+/-)-1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane(DOI) and alpha-methyl-5-HT: 5-HT2 receptor agonistic action on phosphatidylinositol metabolism in the rat fronto-cingulate and entorhinal cortex.
Edwards E; Ashby CR; Wang RY
Neuropharmacology; 1992 Jul; 31(7):615-21. PubMed ID: 1407401
[TBL] [Abstract][Full Text] [Related]
4. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
Cadogan AK; Alexander SP; Boyd EA; Kendall DA
J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo.
Lichtman AH; Hawkins EG; Griffin G; Cravatt BF
J Pharmacol Exp Ther; 2002 Jul; 302(1):73-9. PubMed ID: 12065702
[TBL] [Abstract][Full Text] [Related]
6. Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes.
Gorzalka BB; Hill MN; Sun JC
Eur J Pharmacol; 2005 May; 516(1):28-33. PubMed ID: 15913602
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characteristics and regulation of 5-HT receptor-stimulated phosphoinositide hydrolysis in the rat spinal cord.
Toscano E; Romero G; Oset C; Del Río J
Gen Pharmacol; 1999 Mar; 32(3):351-8. PubMed ID: 10211591
[TBL] [Abstract][Full Text] [Related]
8. Oleamide-mediated sleep induction does not depend on perturbation of membrane homeoviscosity.
Gobbi M; Mennini T; Valle FD; Cervo L; Salmona M; Diomede L
FEBS Lett; 1999 Dec; 463(3):281-4. PubMed ID: 10606738
[TBL] [Abstract][Full Text] [Related]
9. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.
Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M
Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490
[TBL] [Abstract][Full Text] [Related]
10. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
Fone KC; Johnson JV; Bennett GW; Marsden CA
Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
[TBL] [Abstract][Full Text] [Related]
11. Alpha-adrenoceptor-mediated modulation of 5-HT2 receptor agonist induced impulsive responding in a 5-choice serial reaction time task.
Koskinen T; Haapalinna A; Sirviö J
Pharmacol Toxicol; 2003 May; 92(5):214-25. PubMed ID: 12753409
[TBL] [Abstract][Full Text] [Related]
12. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro.
Lees G; Dougalis A
Brain Res; 2004 Jan; 997(1):1-14. PubMed ID: 14715144
[TBL] [Abstract][Full Text] [Related]
14. Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.
Hoi PM; Hiley CR
Br J Pharmacol; 2006 Mar; 147(5):560-8. PubMed ID: 16415907
[TBL] [Abstract][Full Text] [Related]
15. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
Germonpré PR; Joos GF; Pauwels RA
Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice.
Darmani NA
Pharmacol Biochem Behav; 2001 Feb; 68(2):311-7. PubMed ID: 11267636
[TBL] [Abstract][Full Text] [Related]
17. The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist.
Mendelson WB; Basile AS
Neuroreport; 1999 Oct; 10(15):3237-9. PubMed ID: 10574567
[TBL] [Abstract][Full Text] [Related]
18. Behavioural and biochemical evidence that glucocorticoids are not involved in DOI-elicited 5-HT2 receptor down-regulation.
Chaouloff F; Baudrie V; Coupry I
Eur J Pharmacol; 1993 Nov; 249(1):117-20. PubMed ID: 8282013
[TBL] [Abstract][Full Text] [Related]
19. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
[TBL] [Abstract][Full Text] [Related]
20. Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors.
Leggett JD; Aspley S; Beckett SR; D'Antona AM; Kendall DA; Kendall DA
Br J Pharmacol; 2004 Jan; 141(2):253-62. PubMed ID: 14707029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]